Skip to content
lifestyle.longislandreport.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Abeona Therapeutics Inc.
Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
August 13, 2026
Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
August 6, 2026
CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
August 4, 2026
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 3, 2026
Cincinnati Children’s Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
July 21, 2026
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 1, 2026
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
May 26, 2026
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
April 7, 2026
1
2
Next Page
→